Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 40

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 40
---
 approval by Aadi’s board of directors, the directors and executive officers of Aadi, as well as certain of their affiliated entities, in each case solely in their
capacities as stockholders of Aadi, entered into voting and support agreements with Kaken and Aadi (the “Support Agreements”) with respect to 9,649,161 shares of common stock as of the Record Date, representing approximately 39.1% of
shares outstanding. The Support Agreements obligate the directors and executive officers of Aadi (including certain of their affiliated entities) to vote their respective shares of our common stock in favor of the approval of the Divestiture
Agreement and the Divestiture and certain related matters, and against certain matters that would reasonably be expected to impede, interfere with, delay, discourage, adversely affect or inhibit the transactions contemplated by the Divestiture
Agreement. In (1) evaluating and negotiating the Divestiture Agreement; (2) approving the Divestiture Agreement and the transactions contemplated by the Divestiture Agreement, including the Divestiture; and (3) recommending that Aadi
stockholders vote in favor of the approval of the Divestiture Agreement and the Divestiture, Aadi’s board of directors was aware of and considered these interests to the extent that they existed or were otherwise known at the time, among other
matters.

Retention Bonus Letters

We have
entered into retention bonus letters (each, a “Retention Bonus Letter”) with each of Dr. Lennon and Messrs. Giacobello and Ball, pursuant to which the executives are eligible to be paid retention bonuses (each, a “Retention
Bonus”) subject to continued employment with us through the earlier of (i) March 31, 2025, or (ii) the date of a Change in Control (as defined in the applicable Retention Bonus Letter), provided that an executive will remain
eligible to receive the Retention Bonus if his employment is terminated by us other than for Cause, death or disability, or if he resigns for Good Reason (each such term as defined in the applicable Retention Bonus Letter), subject to execution of a
separation agreement and release of claims in favor of Aadi. Although it is expected that the Divestiture will notconstitute a Change in Control for purposes of the Retention Bonus Letters, in an abundance of caution, we are treating
the Retention Bonus Letter as an interest of the Executive Officers in the Divestiture for